Jane Street’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
JT
RCM
DTC
Jane Street's PCVX Position: Q2 2026 in Review
Jane Street reduced its Vaxcyte (PCVX) stake by 97% in Q2 2026, selling an estimated $13.4M and leaving 6,401 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #8703.
Jane Street first reported a position in PCVX in Q2 2020 and has held it in 16 quarters since. The position peaked at $24.5M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- Jane Street held 6,401 shares of Vaxcyte worth $372K as of Q2 2026.
- Jane Street sold 246,476 Vaxcyte shares in Q2 2026, an estimated $13.4M.
- Vaxcyte made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8703 holding.
- Jane Street first reported a position in Vaxcyte in Q2 2020 and has held it in 16 quarters since.
- Jane Street's Vaxcyte position peaked at $24.5M in Q4 2024.
- 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.